Entity Common Stock, Shares Outstanding of NEUROCRINE BIOSCIENCES INC from 22 Jul 2011 to 04 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NEUROCRINE BIOSCIENCES INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 22 Jul 2011 to 04 Feb 2026.
  • NEUROCRINE BIOSCIENCES INC Entity Common Stock, Shares Outstanding for the quarter ending 04 Feb 2026 was 100,363,463, a 0.66% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 100,363,463 +659,936 +0.66% 04 Feb 2026 10-K 11 Feb 2026 2025 FY
Q3 2025 99,705,698 -1,541,213 -1.5% 21 Oct 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 99,181,510 -1,794,739 -1.8% 24 Jul 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 98,965,820 -1,671,407 -1.7% 30 Apr 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 99,703,527 +196,037 +0.2% 05 Feb 2025 10-K 10 Feb 2025 2024 FY
Q3 2024 101,246,911 +2,994,988 +3% 24 Oct 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 100,976,249 +3,323,799 +3.4% 26 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 100,637,227 +3,062,389 +3.1% 25 Apr 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 99,507,490 +2,919,579 +3% 05 Feb 2024 10-K 09 Feb 2024 2023 FY
Q3 2023 98,251,923 +2,117,535 +2.2% 25 Oct 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 97,652,450 +2,013,129 +2.1% 26 Jul 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 97,574,838 +1,998,176 +2.1% 26 Apr 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 96,587,911 +1,345,228 +1.4% 31 Jan 2023 10-K 09 Feb 2023 2022 FY
Q3 2022 96,134,388 +1,267,695 +1.3% 28 Oct 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 95,639,321 +992,894 +1% 28 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 95,576,662 +1,030,671 +1.1% 28 Apr 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 95,242,683 +1,299,038 +1.4% 07 Feb 2022 10-K 11 Feb 2022 2021 FY
Q3 2021 94,866,693 +1,437,540 +1.5% 27 Oct 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 94,646,427 +1,391,555 +1.5% 28 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 94,545,991 +1,680,870 +1.8% 29 Apr 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 93,943,645 +1,651,253 +1.8% 29 Jan 2021 10-K 05 Feb 2021 2020 FY
Q3 2020 93,429,153 +1,335,632 +1.4% 04 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 93,254,872 +1,675,471 +1.8% 28 Jul 2020 10-Q 03 Aug 2020 2020 Q2
Q1 2020 92,865,121 +1,578,198 +1.7% 30 Apr 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 92,292,392 +1,471,125 +1.6% 31 Jan 2020 10-K 07 Feb 2020 2019 FY
Q3 2019 92,093,521 +1,411,339 +1.6% 29 Oct 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 91,579,401 +1,110,040 +1.2% 24 Jul 2019 10-Q 29 Jul 2019 2019 Q2
Q1 2019 91,286,923 +1,389,060 +1.5% 24 Apr 2019 10-Q 29 Apr 2019 2019 Q1
Q4 2018 90,821,267 +1,547,730 +1.7% 01 Feb 2019 10-K 08 Feb 2019 2018 FY
Q3 2018 90,682,182 +2,189,137 +2.5% 30 Oct 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 90,469,361 +2,247,687 +2.5% 25 Jul 2018 10-Q 31 Jul 2018 2018 Q2
Q1 2018 89,897,863 +1,822,900 +2.1% 25 Apr 2018 10-Q 30 Apr 2018 2018 Q1
Q4 2017 89,273,537 +2,159,197 +2.5% 02 Feb 2018 10-K 13 Feb 2018 2017 FY
Q3 2017 88,493,045 +1,621,732 +1.9% 27 Oct 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 88,221,674 +1,470,041 +1.7% 27 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 88,074,963 +1,418,934 +1.6% 03 May 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 87,114,340 +661,346 +0.76% 01 Feb 2017 10-K 14 Feb 2017 2016 FY
Q3 2016 86,871,313 +674,685 +0.78% 27 Oct 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 86,751,633 +878,442 +1% 28 Jul 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 86,656,029 +1,238,232 +1.4% 29 Apr 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 86,452,994 +9,289,646 +12% 01 Feb 2016 10-K 11 Feb 2016 2015 FY
Q3 2015 86,196,628 +10,191,473 +13% 23 Oct 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 85,873,191 +9,953,787 +13% 24 Jul 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 85,417,797 +9,554,763 +13% 24 Apr 2015 10-Q 30 Apr 2015 2015 Q1
Q4 2014 77,163,348 +9,369,639 +14% 26 Jan 2015 10-K 09 Feb 2015 2014 FY
Q3 2014 76,005,155 +8,661,761 +13% 27 Oct 2014 10-Q 04 Nov 2014 2014 Q3
Q2 2014 75,919,404 +8,857,118 +13% 31 Jul 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 75,863,034 +9,130,666 +14% 25 Apr 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 67,793,709 +1,284,452 +1.9% 24 Jan 2014 10-K 11 Feb 2014 2013 FY
Q3 2013 67,343,394 +958,704 +1.4% 23 Oct 2013 10-Q 29 Oct 2013 2013 Q3
Q2 2013 67,062,286 +737,040 +1.1% 19 Jul 2013 10-Q 26 Jul 2013 2013 Q2
Q1 2013 66,732,368 +425,171 +0.64% 26 Apr 2013 10-Q 02 May 2013 2013 Q1
Q4 2012 66,509,257 +269,762 +0.41% 31 Jan 2013 10-K 08 Feb 2013 2012 FY
Q3 2012 66,384,690 +11,128,009 +20% 25 Oct 2012 10-Q 31 Oct 2012 2012 Q3
Q2 2012 66,325,246 +11,086,050 +20% 24 Jul 2012 10-Q 31 Jul 2012 2012 Q2
Q1 2012 66,307,197 27 Apr 2012 10-Q 02 May 2012 2012 Q1
Q4 2011 66,239,495 31 Jan 2012 10-K 09 Feb 2012 2011 FY
Q3 2011 55,256,681 26 Oct 2011 10-Q 31 Oct 2011 2011 Q3
Q2 2011 55,239,196 22 Jul 2011 10-Q 29 Jul 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.